ArticleOrphanet journal of rare diseases2022

A Japanese single-center experience of the efficacy and safety of asfotase alfa in pediatric-onset hypophosphatasia.

Yohei Sugiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.